Skip to main content
Log in

Are Pharmacists a Viable Channel for Education about Clinical Trial Participation?

  • Clinical Trials
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

Clinical research is fundamental to improving public health, yet public awareness of and engagement in clinical research is very low, as is public trust in the clinical research enterprise. Hypothesizing that pharmacists represent an untapped resource to educate and engage the public about clinical research, this study examines public perspectives on receiving clinical research information from pharmacists. In a 19-item survey, the majority (72%) of the 2,650 respondents were very or somewhat interested in receiving clinical trial information from a pharmacist; but <1% currently receive it and <2% ever asked. Primary interests include information about finding a trial, safety of trials, and ways to learn more; printed information provided at the pharmacy or by email are preferred methods of receiving information. Interest varies significantly among respondent groups, but excepting non-pharmacy users, all respondents desire information at rates greater than 65%, regardless of demographics, knowledge or experience of clinical trials, and patient-pharmacist relationships. These results suggest that pharmacy-directed outreach and recruitment strategies could see high rates of success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Woolley M, Propst S. Public attitudes and perceptions about health-related research. JAMA. 2005;294:1380–1384.

    Article  Google Scholar 

  2. Research Enterprise Poll. Alexandria, VA: Research! America; 2010. http://www.researchamerica.org/uploads/ResearchEnterprisePoll.pdf (accessed October 18, 2010).

  3. Getz K. Public confidence and trust today: a review of public opinion polls. The Monitor. September 17–21. http://216.147.199.31/Monitor/2008September/Getzl.pdf (accessed October 18, 2010).

  4. Harris Interactive. New survey shows public perception of opportunities for participation in clinical trials has decreased slightly from last year. HealthCare News. 2005;5(6):1–14. http://www.harrisinteractive.com/news/newsletters/healthnews/HI_HealthCareNews200SVo15_lss06.pdf (accessed December 27, 2010).

  5. Sung NS, Crowley WF Jr, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278–1287.

    Article  Google Scholar 

  6. Harris Interactive. Lack of trust in both FDA and pharmaceutical companies makes drug safety a concern for many. HealthCare News. 2007;7(6): 1–5. http://www.harrisinteractive.com/news/newsletters/healthnews/H.I_HealthCareNews_2007_v07_i06.pdf (accessed December 27, 2010).

  7. Braunstein J, Sherber N, Schulman S, Ding E, Powe N. Race, medical researcher distrust, perceived harm and willingness to participate in cardiovascular prevention trials. Medicine. 2008; 87(1):1–9.

    Article  Google Scholar 

  8. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112(2):228–242.

    Article  Google Scholar 

  9. Getz K. Survey of 1,170 adults at the Clinical Trial Congress in Philadelphia. Institute for International Research. February 2004.

  10. Comis RL, Miller JD, Aldigé CR, Kres L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21:830–835.

    Article  Google Scholar 

  11. Harris Interactive. Oil, pharmaceutical, health insurance, and tobacco top the list of industries that people think should be more regulated. Harris Poll. December 2, 2010: 1–4. http://www.harrisinteractive.com/vault/HI-Harris-Poll-Industry-Reguiation-2010-12-02.pdf (accessed December 27, 2010).

  12. Borfitz D. Will physicians refer their patient into clinical trials? CenterWatch Monthly Newsletter. 2004;11(3):5–7.

    Google Scholar 

  13. Honesty/ethics in professions. Gallup website. November 20–22, 2009. http://www.gallup.com/poll/1654/honesty-ethics-professions.aspx (accessed October 18, 2010).

  14. Wilson Health Information. WilsonRX Pharmacy Satisfaction Survey. New Hope, PA: Wilson Health Information; 2008. http://www.pharmacysatisfaction.com/resources/pdf/PharmacySatisfactionDigest_2008.pdf(accessed May 31, 2010).

  15. Cull WL, O’Connor KG, Sharp S, Tang SS. Response rates and response bias for 50 surveys of pediatricians. Health Serv Res. 2005;40(1):213– 226.

    Article  Google Scholar 

  16. Tolonen H, Helakorpi S, Talala K, Helasoja V, Martelin T, Prättälä R. 25-year trends and socio-demographic differences in response rates: Finnish adult health behavior survey. Eur J Epidemiol. 2006;21:409–415.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diane Simmons BA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simmons, D., Chapped, J., Getz, K.A. et al. Are Pharmacists a Viable Channel for Education about Clinical Trial Participation?. Ther Innov Regul Sci 45, 443–453 (2011). https://doi.org/10.1177/009286151104500406

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286151104500406

Key Words

Navigation